Management of metastatic melanoma in Texas: disparities in the utilization of immunotherapy following the regulatory approval of immune checkpoint inhibitors.
Olajumoke Adenike OlatejuZhen ZengJames Douglas ThorntonOsaro MgbereEkere James EssienPublished in: BMC cancer (2023)
This cohort study identified sociodemographic and socioeconomic disparities in access to immunotherapy in Texas, highlighting the need for policies such as Medicaid expansion that would increase equitable access to this innovative therapy.